Bladder cancer: Pre-existing immunity to BCG can boost clinical response to intravesical therapy.

Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer.

Biot C, Rentsch CA, Gsponer JR, Birkh?user FD, Jusforgues-Saklani H, Lema?tre F, Auriau C, Bachmann A, Bousso P, Demangel C, et al. Sci Transl Med. 2012 Jun 6; 4(137):137ra72.

Source: http://www.ncbi.nlm.nih.gov/PubMed/22732859?dopt=Abstract

liquidmetal gsa scandal kelis dick clark dies ibogaine jamie moyer bone cancer